Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2008-09-09
2008-09-09
Blanchard, David J. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387300, C530S388100, C530S391300, C530S391700, C424S130100, C424S133100, C424S141100, C424S155100, C435S069600
Reexamination Certificate
active
10063519
ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: 5536637 (1996-07-01), Jacobs
patent: 6025156 (2000-02-01), Gwynn et al.
patent: 6124433 (2000-09-01), Falb et al.
patent: 6156500 (2000-12-01), Falb
patent: 6162604 (2000-12-01), Jacob
patent: 6204371 (2001-03-01), Levinson
patent: 6228582 (2001-05-01), Rodier et al.
patent: 6395306 (2002-05-01), Cui et al.
patent: 6414117 (2002-07-01), Levinson
patent: 6465185 (2002-10-01), Goldfine et al.
patent: 6498235 (2002-12-01), Sheppard et al.
patent: 6534641 (2003-03-01), Falb et al.
patent: 6562343 (2003-05-01), Levinson
patent: 6645499 (2003-11-01), Lal et al.
patent: 6730502 (2004-05-01), Van Hijum et al.
patent: 6737522 (2004-05-01), Sundick et al.
patent: WO 97/38085 (1997-10-01), None
patent: WO 0153312 (2001-07-01), None
Hu et al. (2003, Journal of Proteome Research 2:405-412.
Haynes et al. (1998, Electrophoresis 1921862-1871.
Fu et al (EMBO Journal, 1996, vol. 15, pp. 4392-4401.
Powell et al (Pharmacogenesis, 1998, vol. 8, pp. 411-421, abstract.
Vallejo et al (Biochimie, 2000, vol. 82, pp. 1129-1133, abstract.
Pennica et al (PNAS 95:14717-22, 1998.
Jang et al (Clinical and Experimental Metastasis, 1997, vol. 15, pp. 469-483, abstract.
Gokmen-Polar et al Cancer Res 61:1375-1381, 2001.
Klein et al. Selection for Genes Encoding Secreted Proteins and Receptors.Proc. Natl. Acad. Sci., 93:7108-7113 (1996).
Database Search, DNA Sequence Alignments [BLASTN 2.2.1[Jul. 12, 2001], NCBI].
Database Search, Protein Sequence Alignments [BLASTN 2.2.1[Jul. 12, 2001], NCBI].
Alberts, et al. 1994.Molecular Biology of the Cell, 3rd Edition, pp. 403-404, 453. New York: Garland Publishing.
Alberts, et al. 2002.Molecular Biology of the Cell 4th Edition, pp. 302, 363-364, 379, 435. New York: Garland Publishing.
The 1991 Boehringer Mannheim Biochemicals Catalog, p. 557, 1991.
Burgess, et al. 1990, Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue.The Journal of Cell Biology, 111:2129-2138.
Grimaldi, et al. 1989. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene.Blood, 73(8):2081-2085.
Gygi, et al. 1999. Correlation between protein and mRNA abundance in yeast.Molecular and Cellular Biology, 19(3):1720-1730.
Hanna, et al. Aug. 1999. HER-2
eu breast cancer predictive testing.Pathology Associates Medical Laboratories.
Lazar, et al. 1988. Transforming growth factor α: Mutation of aspartic acid 47 and leucine 48 results in different biological activities.Molecular and Cellular Biology, 8(3):1247-1252.
Lewin, B. 1994. Oncogenes: Gene expression and cancer, Chap. 39, pp. 1196-1201.Genes V. New York: Oxford University Press.
Lewin, B. 1997. Regulation of Transcription, Chap. 29, pp. 847-848.Genes VI. New York: Oxford University Press.
Lin, et al. 1975. Structure-function relationships in glucagon: Properties of highly purified Des-His1-, Monoiodo-,and [Des-Asn28, Thr29](homoserine lacton27)-glucagon.Biochemistry, 14(8):1559-1563.
Meeker, et al. 1990. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia.Blood, 76(2):285-289.
Meric, et al. 2002. Translation initiation in cancer: A novel target for therapy.Molecular Cancer Therapeutics, 1:971-979.
Singleton, et al. 1992. Clinical and pathologic significance of the c-erbB-2 (HER-2
eu) oncogene.Pathol. Annu., 1(27):165-190.
Schwartz, et al. 1987. A superactive insulin: [B10-aspartic acid]insulin(human).Proc. Natl. Acad. Sci. USA, 84:6408-6411.
Zhigang, et al. 2004. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer.World Journal of Surgical Oncology, 2:13.
2002-2003 Catalog & Technical Reference, New England BioLabs, Inc., p. 122.
Alberts, et al. 1994.Molecular Biology of the Cell, 3rd Edition, pp. 1216-1217, New York: Garland Publishing.
Allman, et al. 1996. BCL-6 expression during B-cell activation.Blood, 87(12):5257-5268.
Chen, et al. 2002. Discordant protein and mRNA expression in lung adenocarcinomas.Molecular&Cellular Proteomics 1.4, pp. 304-313.
Fessler, et al. 2002. A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase.The Journal of Biological Chemistry, 277(35):31291-31302.
Hanash, S. 2003. Making sense of microarray data to classify cancer.The Pharmacogenomics Journal, 3:308-311.
Hanash, S. Mar. 2005. Integrated global profiling of cancer.Nature Reviews, Applied Proteomics Collection, pp. 9-14.
Hancock, W. S. 2004. Do we have enough biomarkers?Journal of Proteome Research, 3(4):685.
Hyman, et al. 2002. Impact of DNA amplification on gene expression patterns in breast cancer.Cancer Research, 62:6240-6245.
Konopka, et al. 1986. Variable expression of the translocatedc-abloncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.Proc. Natl. Acad. Sci. USA, 83:4049-4052.
Ohara, et al. 2001. Directional cDNA library construction assisted by thein vitrorecombination reaction.Nucleic Acids Research, 29(4):e22 p. 1-8.
Ørntoft, et al. 2002. Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas.Molecular&Cellular Proteomics, 1:37-45.
Pollack, et al. 2002. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.PNAS, 99(20):12963-12968.
Tokunaga, et al. 2000. Application of quantitative RT-PCR using “TaqMan” technology to evaluate the expression of CK 18 mRNA in various cell lines.J. Exp. Clin. Cancer Res., 19(3):375-381.
Wang, et al. 1996. mRNA Differential display: Application in the discovery of novel pharmacological targets.Trends Pharmacol. Sci., 17(8):276-279.
Anderson, et al. 1997. A comparison of selected mRNA and protein abundances in human liver.Electrophoresis, 18:533-537.
Abe, et al. “An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue.”Br J Cancer. Dec. 1, 2003;89(11):2104-9. (Abstract Only).
Ando, et al. “Selective apoptosis of natural killer-cell tumours by I-asparaginase.”Br. J. Haematol. Sep. 2005;130(6):860-8. (Abstract Only).
Aust, et al. “Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1-messenger-RNA and protein.”Thyroid. Oct. 1997;7(5):713-24. (Abstract Only).
Barnes, et al. “Expression of embryonic fibronection isoform EIIIA parallels alpha-smooth muscle actin in maturing and diseased kidney.”J Histochem Cytochem. Jun. 1999;47(6):787-98. (Abstract Only).
Bea, et al. “BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas.”Cancer Res. Mar. 15, 2001;61(6):2409-12. (Abstract Only).
Blaschke, et al. “Rapid quantitation of proinflammatory and chemoattractant cytokine expression in small tissue samples and monocyte-derived dendritic cells: validation of a new real-time RT-PCR technology.”J Immunol Methods. Dec. 1, 2000;246(1-2):79-90. (Abstract Only).
Buckley, et al. “Butyrate-induced reversal of dexamethasone resistance in autonomous rat Nb2 lymphoma cells.
Goddard Audrey
Godowski Paul J.
Grimaldi J. Christopher
Gurney Austin L.
Wood William I.
Barnes Elizabeth M.
Blanchard David J.
Genentech Inc.
Knobbe Martens Olson & Bear LLP
Kresnak Mark T.
LandOfFree
Antibodies to a polypeptide encoded by a nucleic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to a polypeptide encoded by a nucleic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to a polypeptide encoded by a nucleic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3919374